| Stock |
Weight |
Amount |
| Regeneron Pharmaceuticals |
10.96% |
$369,104,105 |
| Gilead Sciences |
8.47% |
$285,079,043 |
| Amgen |
7.20% |
$242,555,923 |
| Celgene |
6.55% |
$220,735,038 |
| Alexion Pharmaceuticals |
6.10% |
$205,343,272 |
| Biogen Idec |
5.99% |
$201,708,432 |
| Vertex Pharmaceuticals |
4.76% |
$160,338,745 |
| Perrigo Co. |
3.21% |
$108,081,015 |
| Biomarin Pharmaceutical |
3.16% |
$106,281,161 |
| Onyx Pharmaceuticals |
2.76% |
$92,982,163 |
| Mylan |
2.49% |
$83,995,330 |
| Illumina |
2.32% |
$78,108,042 |
| Life Technologies |
1.58% |
$53,136,528 |
| Theravance |
1.20% |
$40,295,586 |
| Seattle Genetics |
1.20% |
$40,497,805 |
| United Therapeutics |
1.15% |
$38,827,809 |
| Salix Pharmaceuticals Ltd |
1.12% |
$37,584,470 |
| Cubist Pharmaceuticals |
1.08% |
$36,328,534 |
| Medivation |
1.06% |
$35,827,012 |
| Alkermes Plc |
1.05% |
$35,374,460 |
| Page 1 2 3 4 5 6 next » |
|
